Table 1.
Gene | % of patients with pancreatic cancer | Increased Risk | Age 50+ | Age 70 |
---|---|---|---|---|
SEER USA population | – | 1 | 0.05% | 0.5% |
Hereditary non-polyposis colorectal cancer (Lynch syndrome) genes | < 1 | 7–8 | 0.4% | 4% |
ATM | 1–4 | 6 | 0.3% | 3% |
BRCA2 | 2–7 | 2–6 | Up to 0.3% | Up to 3% |
BRCA1 | Up to 1 | 1–2.5 | Up to 0.15% | |
PALB2 | < 1 | 2.4 | 0.12% | 1.2% |
p16/CDKN2A | 1–3 | 12–46 | Up to 2.3% | Up to 23% |
PRSS1 | < 1 | 50–60 | 3% | 30% |
STK11 | < 1 | 75–135 | 6.75% | Up to 67.5% |
TP53 | < 1 | 6–7 | 0.35% | Up to 3.5% |
+Using the high end of the range of increased risk